
Drugs IPOs Depend o...


| Sep 2012 | Sep 2011 | |||
| Sales | 336.39M | 264.54M | ||
| Cost of Sales | 236.83M | 179.40M | ||
| Gross Operating Profit | 99.56M | 85.14M | ||
| Selling, General, and Administrative Expenses | 77.55M | 69.97M | ||
| Research & Development | 0.00 | 0.00 | ||
| Operating Income before D & A (EBITDA) | 22.01M | 15.17M | ||
| Depreciation & Amortization | 10.02M | 7.76M | ||
| Interest Income | 6.10K | 10.08K | ||
| Other Income - Net | 0.00 | 24.71K | ||
| Special Income / Charges | 0.00 | 0.00 | ||
| Total Income Before Interest Expenses (EBIT) | 12.00M | 7.45M | ||
| Interest Expense | 568.50K | 669.12K | ||
| Pre-Tax Income | 11.43M | 6.78M | ||
| Income Taxes | 3.96M | 2.17M | ||
| Minority Interest | 827.77K | 1.11M | ||
| Net Income From Continuing Operations | 6.65M | 3.50M | ||
| Net Income From Discontinued Operations | 0.00 | 0.00 | ||
| Net Income From Total Operations | 6.65M | 3.50M | ||
| Extraordinary Income/Losses | 0.00 | 0.00 | ||
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | ||
| Income From Tax Loss Carryforward | 0.00 | 0.00 | ||
| Other Gains / Losses | 0.00 | 0.00 | ||
| Total Net Income | 6.65M | 3.50M | ||
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
6.65M | 3.50M | ||
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 6.65M | 3.50M | ||
| Basic EPS from Continuing Ops. | 0.30 | 0.00 | ||
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | ||
| Basic EPS from Total Operations | 0.30 | 0.00 | ||
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | ||
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | ||
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | ||
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | ||
| Basic EPS, Total | 0.30 | 0.00 | ||
| Basic Normalized Net Income/Share | 0.30 | n.a. | ||
| EPS fr Continuing Ops. | 0.30 | 0.00 | ||
| EPS fr Discontinued Ops | 0.00 | 0.00 | ||
| EPS fr Total Ops. | 0.30 | 0.00 | ||
| EPS fr Extraord. Inc. | 0.00 | 0.00 | ||
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | ||
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | ||
| EPS fr Other Gains (L) | 0.00 | 0.00 | ||
| EPS, Total | 0.30 | 0.00 | ||
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0.30 | n.a. | ||
| Dividends Paid per Share | 0.00 | 0.00 | ||